Pivot
Total Raised
$48.64MInvestors Count
12Deal Terms
1Funding, Valuation & Revenue
7 Fundings
Pivot has raised $48.64M over 7 rounds.
Pivot's latest funding round was a Series D for $9.64M on October 13, 2021.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/13/2021 | Series D | $9.64M | 2 | |||
4/9/2020 | Loan | |||||
4/3/2020 | Series C | |||||
10/29/2018 | Series B | |||||
8/15/2017 | Series A - II |
Date | 10/13/2021 | 4/9/2020 | 4/3/2020 | 10/29/2018 | 8/15/2017 |
|---|---|---|---|---|---|
Round | Series D | Loan | Series C | Series B | Series A - II |
Amount | $9.64M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 |
Pivot Deal Terms
1 Deal Term
Pivot's deal structure is available for 1 funding round, including their Series A - II from August 15, 2017.
Round | Series A - II |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A - II |
Pivot Investors
12 Investors
Pivot has 12 investors. Khosla Ventures invested in Pivot's Series D funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/1/2015 | 10/13/2021 | 4 Series A, Series A - II (2017), Series C (2020), Series D (2021) | Venture Capital | California | ||
10/29/2018 | 10/13/2021 | 3 Series B, Series C (2020), Series D (2021) | Incubator/Accelerator | New Jersey | ||
10/13/2021 | 10/13/2021 | 1 Series D | Private Equity | Illinois | ||
Government | DC | |||||
Angel Investor (Individual) |
First funding | 4/1/2015 | 10/29/2018 | 10/13/2021 | ||
|---|---|---|---|---|---|
Last Funding | 10/13/2021 | 10/13/2021 | 10/13/2021 | ||
Investor | |||||
Rounds | 4 Series A, Series A - II (2017), Series C (2020), Series D (2021) | 3 Series B, Series C (2020), Series D (2021) | 1 Series D | ||
Board Seats | |||||
Type | Venture Capital | Incubator/Accelerator | Private Equity | Government | Angel Investor (Individual) |
Location | California | New Jersey | Illinois | DC |
Compare Pivot to Competitors
LUMMÉ develops technology platforms in the health sector, focusing on weight management and smoking cessation. The company provides smartwatch applications that offer interventions to assist in health behavior modifications. LUMMÉ's products are aimed at individuals managing their weight or attempting to quit smoking using wearable technology. It was founded in 2014 and is based in Boston, Massachusetts.
2Morrow is a company involved in digital health and well-being programs across various sectors. They provide a behavior modification platform and health and wellness resources intended for individuals to pursue their health goals. The company's programs are available via a smartphone app and are supported by clinical evidence and research. It was founded in 2012 and is based in Kirkland, Washington.
AYR is a technology company focused on healthcare innovation, providing a product designed to help individuals quit smoking by offering insights and support to break tobacco dependency. AYR caters to the healthcare sector, focusing on individuals looking to quit smoking. AYR was formerly known as Beyond Twenty. It was founded in 2015 and is based in London, United Kingdom.
Pelago operates as a virtual clinic focused on substance use management within the healthcare sector. The company provides evidence-based solutions for managing tobacco, alcohol, opioid, and cannabis use, including cognitive behavioral therapy (CBT), medication-assisted treatment (MAT), and remote monitoring. Pelago serves employers and health plans. Pelago was formerly known as Quit Genius. It was founded in 2017 and is based in San Francisco, California.
Pack is a technology-driven company focused on the smoking cessation industry. Its main service involves providing a digital solution to assist individuals in quitting smoking. It was founded in 2014 and is based in San Francisco, California.
Smokeless is a company that provides a smoking cessation program through behavioral therapy and nicotine reduction technology. Its main offerings include a smoking cessation program that utilizes an inhaler device to automate nicotine intake reduction, supported by an app that tracks progress. It was founded in 2017 and is based in Grunwald, Germany.
Loading...